Literature DB >> 33767783

Relationship between TP53 and interleukin-6 gene variants and the risk of types 1 and 2 diabetes mellitus development in the Kermanshah province.

Lida Haghnazari1, Ramin Sabzi2.   

Abstract

Diabetes mellitus (DM) is a metabolic disorder that results from insufficient secretion or insulin resistance, or both. Insulin secretion deficiency leads to chronic hyperglycemia along with impaired metabolism of proteins, lipids, and carbohydrates. This study aimed to investigate the TP53 gene SNP (single nucleotide polymorphism) rs1042522 genotype and the interleukin-6 (IL-6) gene SNP rs1800795 genotype in DM and control groups. This study was performed on 70 patients with type 1 DM, 100 patients with type 2 DM without related complications, 66 control subjects for type 1 DM, and 95 control subjects for type 2 DM. The control groups were matched regarding age and gender and did not have a familial relationship with the patient groups. All the subjects were residents of Kermanshah, located in the western part of Iran. Polymorphisms of TP53 and IL-6 genes were determined by the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. Lipid profile, fasting blood glucose, and HbA1c were measured using the ELISA and immunoturbidometric methods. The frequency of genotypes (CC, CG, GG) of the TP53 gene codon 72 in type 1 DM and its control group were significantly different (P= 0.013). Likewise, the frequency of genotypes (CC, CG, GG) of the TP53 gene codon 72 was significantly different between type 2 DM and control groups (P <0.001). The frequency of genotypes (GG, GC, CC) of G174C polymorphisms in the IL-6 gene was different between type 1 DM and control group as well as between type 2 DM and its control group, but it was not statistically significant. SNP rs1042522 genotypes in the dominant form (CG + GG vs. CC) (OR= 3.880; P < 0.001) and alleles G vs. C alleles (OR= 0.384; P < 0.001) increased the risk of type 2 DM significantly. There was no significant difference between type 1 and type 2 DM groups and respected control groups regarding the frequency of the IL-6 gene SNP rs1800795 alleles. The G allele of SNP rs1042522 encoding the TP53 gene increases the risk of developing DM in the population of the Kermanshah province, Iran. ©2020 JOURNAL of MEDICINE and LIFE.

Entities:  

Keywords:  TP53; interleukin-6; single nucleotide polymorphism; type 1 diabetes mellitus; type 2 diabetes mellitus

Mesh:

Substances:

Year:  2021        PMID: 33767783      PMCID: PMC7982265          DOI: 10.25122/jml-2019-0150

Source DB:  PubMed          Journal:  J Med Life        ISSN: 1844-122X


  20 in total

1.  Doubling the burden: chronic disease.

Authors:  Sally Murray
Journal:  CMAJ       Date:  2006-03-14       Impact factor: 8.262

2.  Nine-amino-acid transactivation domain: establishment and prediction utilities.

Authors:  Simona Piskacek; Martin Gregor; Maria Nemethova; Martin Grabner; Pavel Kovarik; Martin Piskacek
Journal:  Genomics       Date:  2007-04-30       Impact factor: 5.736

3.  Central role of p53 in the suntan response and pathologic hyperpigmentation.

Authors:  Rutao Cui; Hans R Widlund; Erez Feige; Jennifer Y Lin; Dara L Wilensky; Viven E Igras; John D'Orazio; Claire Y Fung; Carl F Schanbacher; Scott R Granter; David E Fisher
Journal:  Cell       Date:  2007-03-09       Impact factor: 41.582

4.  Effects of three Mexican medicinal plants (Asteraceae) on blood glucose levels in healthy mice and rabbits.

Authors:  F J Alarcon-Aguilar; R Roman-Ramos; M Jimenez-Estrada; R Reyes-Chilpa; B Gonzalez-Paredes; J L Flores-Saenz
Journal:  J Ethnopharmacol       Date:  1997-02       Impact factor: 4.360

5.  Epidemiology of type 2 diabetes: Indian scenario.

Authors:  V Mohan; S Sandeep; R Deepa; B Shah; C Varghese
Journal:  Indian J Med Res       Date:  2007-03       Impact factor: 2.375

Review 6.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

7.  p53 polymorphic variants at codon 72 exert different effects on cell cycle progression.

Authors:  David Pim; Lawrence Banks
Journal:  Int J Cancer       Date:  2004-01-10       Impact factor: 7.396

8.  Increase in incidence of insulin-dependent diabetes mellitus among children in Finland.

Authors:  J Tuomilehto; E Virtala; M Karvonen; R Lounamaa; J Pitkäniemi; A Reunanen; E Tuomilehto-Wolf; L Toivanen
Journal:  Int J Epidemiol       Date:  1995-10       Impact factor: 7.196

9.  The P72R Polymorphism of p53 Predisposes to Obesity and Metabolic Dysfunction.

Authors:  Che-Pei Kung; Julia I-Ju Leu; Subhasree Basu; Sakina Khaku; Frederick Anokye-Danso; Qin Liu; Donna L George; Rexford S Ahima; Maureen E Murphy
Journal:  Cell Rep       Date:  2016-03-03       Impact factor: 9.423

10.  Lack of association between rs1800795 (-174 G/C) polymorphism in the promoter region of interleukin-6 gene and susceptibility to type 2 diabetes in Isfahan population.

Authors:  Reza Ghavimi; Mohammadreza Sharifi; Mohammad Ali Mohaghegh; Hossein Mohammadian; Saedeh Khadempar; Hamzeh Rezaei
Journal:  Adv Biomed Res       Date:  2016-02-08
View more
  1 in total

1.  IL-6 gene rs1800795 polymorphism and diabetes mellitus: a comprehensive analysis involving 42,150 participants from a meta-analysis.

Authors:  Zhiying Cheng; Chunmin Zhang; Yuanyuan Mi
Journal:  Diabetol Metab Syndr       Date:  2022-07-15       Impact factor: 5.395

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.